Risk-adjusted outcomes in elderly endometrial cancer patients

Implications of the contrasting impact of age on progression-free and cause-specific survival

Mariam M. Alhilli, Jamie N Bakkum-Gamez, Andrea Mariani, Amy L. Weaver, Michaela E. McGree, Gary Keeney, Aminah Jatoi, Sean Christopher Dowdy, Karl C. Podratz

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objective To reexamine the tenet that advanced age independently impacts progression-free and cause-specific survival in patients with endometrial cancer (EC). Methods Patients undergoing surgery for stages I-IIIC EC between 1999 and 2008 were stratified by age (< 70 vs 70 years). Three propensity score (PS) methods were utilized to adjust for confounding risk factors. The PS, or conditional probability of being 70 years old, given a patient's baseline covariates, was derived using logistic regression. The Cox proportional hazards models were fit to estimate the effect of age 70 years on outcomes. Results Of 1182 eligible patients, 822 (69.5%) were < 70 and 360 (30.5%) were 70. Patients 70 were more likely to have multiple adverse risk factors. The total standardized difference of these factors was reduced by 74% and 81%, respectively, using PS-stratification and PS-matching analyses. The nonsignificant trend toward an association between progression-free survival and age 70 in an unadjusted analysis (hazard ratio [HR], 1.40; 95% CI, 0.95-2.04) was further attenuated in the 3 PS analyses. The unadjusted HR for the association between age 70 and cause-specific survival was 2.03 (95% CI, 1.32-3.13). HRs were attenuated in PS analyses but retained significance (except for PS matching), potentially reflecting differences in salvage therapies (P <.001), including a 3-fold greater use of chemotherapy in those < 70. Conclusion When risk-adjusted for the higher prevalence of adverse prognostic factors in elderly EC patients, progression-free survival after primary therapy is not age dependent but the less favorable cause-specific survival in this cohort may reflect age-related postrecurrence treatment differences.

Original languageEnglish (US)
Pages (from-to)133-140
Number of pages8
JournalGynecologic Oncology
Volume138
Issue number1
DOIs
StatePublished - Jul 1 2015

Fingerprint

Propensity Score
Endometrial Neoplasms
Survival
Disease-Free Survival
Salvage Therapy
Proportional Hazards Models
Logistic Models
Drug Therapy
Therapeutics

Keywords

  • Endometrial cancer Elderly

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Risk-adjusted outcomes in elderly endometrial cancer patients : Implications of the contrasting impact of age on progression-free and cause-specific survival. / Alhilli, Mariam M.; Bakkum-Gamez, Jamie N; Mariani, Andrea; Weaver, Amy L.; McGree, Michaela E.; Keeney, Gary; Jatoi, Aminah; Dowdy, Sean Christopher; Podratz, Karl C.

In: Gynecologic Oncology, Vol. 138, No. 1, 01.07.2015, p. 133-140.

Research output: Contribution to journalArticle

@article{271152a8ee4c42a382b8b61acecbd4dc,
title = "Risk-adjusted outcomes in elderly endometrial cancer patients: Implications of the contrasting impact of age on progression-free and cause-specific survival",
abstract = "Objective To reexamine the tenet that advanced age independently impacts progression-free and cause-specific survival in patients with endometrial cancer (EC). Methods Patients undergoing surgery for stages I-IIIC EC between 1999 and 2008 were stratified by age (< 70 vs 70 years). Three propensity score (PS) methods were utilized to adjust for confounding risk factors. The PS, or conditional probability of being 70 years old, given a patient's baseline covariates, was derived using logistic regression. The Cox proportional hazards models were fit to estimate the effect of age 70 years on outcomes. Results Of 1182 eligible patients, 822 (69.5{\%}) were < 70 and 360 (30.5{\%}) were 70. Patients 70 were more likely to have multiple adverse risk factors. The total standardized difference of these factors was reduced by 74{\%} and 81{\%}, respectively, using PS-stratification and PS-matching analyses. The nonsignificant trend toward an association between progression-free survival and age 70 in an unadjusted analysis (hazard ratio [HR], 1.40; 95{\%} CI, 0.95-2.04) was further attenuated in the 3 PS analyses. The unadjusted HR for the association between age 70 and cause-specific survival was 2.03 (95{\%} CI, 1.32-3.13). HRs were attenuated in PS analyses but retained significance (except for PS matching), potentially reflecting differences in salvage therapies (P <.001), including a 3-fold greater use of chemotherapy in those < 70. Conclusion When risk-adjusted for the higher prevalence of adverse prognostic factors in elderly EC patients, progression-free survival after primary therapy is not age dependent but the less favorable cause-specific survival in this cohort may reflect age-related postrecurrence treatment differences.",
keywords = "Endometrial cancer Elderly",
author = "Alhilli, {Mariam M.} and Bakkum-Gamez, {Jamie N} and Andrea Mariani and Weaver, {Amy L.} and McGree, {Michaela E.} and Gary Keeney and Aminah Jatoi and Dowdy, {Sean Christopher} and Podratz, {Karl C.}",
year = "2015",
month = "7",
day = "1",
doi = "10.1016/j.ygyno.2015.04.010",
language = "English (US)",
volume = "138",
pages = "133--140",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Risk-adjusted outcomes in elderly endometrial cancer patients

T2 - Implications of the contrasting impact of age on progression-free and cause-specific survival

AU - Alhilli, Mariam M.

AU - Bakkum-Gamez, Jamie N

AU - Mariani, Andrea

AU - Weaver, Amy L.

AU - McGree, Michaela E.

AU - Keeney, Gary

AU - Jatoi, Aminah

AU - Dowdy, Sean Christopher

AU - Podratz, Karl C.

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Objective To reexamine the tenet that advanced age independently impacts progression-free and cause-specific survival in patients with endometrial cancer (EC). Methods Patients undergoing surgery for stages I-IIIC EC between 1999 and 2008 were stratified by age (< 70 vs 70 years). Three propensity score (PS) methods were utilized to adjust for confounding risk factors. The PS, or conditional probability of being 70 years old, given a patient's baseline covariates, was derived using logistic regression. The Cox proportional hazards models were fit to estimate the effect of age 70 years on outcomes. Results Of 1182 eligible patients, 822 (69.5%) were < 70 and 360 (30.5%) were 70. Patients 70 were more likely to have multiple adverse risk factors. The total standardized difference of these factors was reduced by 74% and 81%, respectively, using PS-stratification and PS-matching analyses. The nonsignificant trend toward an association between progression-free survival and age 70 in an unadjusted analysis (hazard ratio [HR], 1.40; 95% CI, 0.95-2.04) was further attenuated in the 3 PS analyses. The unadjusted HR for the association between age 70 and cause-specific survival was 2.03 (95% CI, 1.32-3.13). HRs were attenuated in PS analyses but retained significance (except for PS matching), potentially reflecting differences in salvage therapies (P <.001), including a 3-fold greater use of chemotherapy in those < 70. Conclusion When risk-adjusted for the higher prevalence of adverse prognostic factors in elderly EC patients, progression-free survival after primary therapy is not age dependent but the less favorable cause-specific survival in this cohort may reflect age-related postrecurrence treatment differences.

AB - Objective To reexamine the tenet that advanced age independently impacts progression-free and cause-specific survival in patients with endometrial cancer (EC). Methods Patients undergoing surgery for stages I-IIIC EC between 1999 and 2008 were stratified by age (< 70 vs 70 years). Three propensity score (PS) methods were utilized to adjust for confounding risk factors. The PS, or conditional probability of being 70 years old, given a patient's baseline covariates, was derived using logistic regression. The Cox proportional hazards models were fit to estimate the effect of age 70 years on outcomes. Results Of 1182 eligible patients, 822 (69.5%) were < 70 and 360 (30.5%) were 70. Patients 70 were more likely to have multiple adverse risk factors. The total standardized difference of these factors was reduced by 74% and 81%, respectively, using PS-stratification and PS-matching analyses. The nonsignificant trend toward an association between progression-free survival and age 70 in an unadjusted analysis (hazard ratio [HR], 1.40; 95% CI, 0.95-2.04) was further attenuated in the 3 PS analyses. The unadjusted HR for the association between age 70 and cause-specific survival was 2.03 (95% CI, 1.32-3.13). HRs were attenuated in PS analyses but retained significance (except for PS matching), potentially reflecting differences in salvage therapies (P <.001), including a 3-fold greater use of chemotherapy in those < 70. Conclusion When risk-adjusted for the higher prevalence of adverse prognostic factors in elderly EC patients, progression-free survival after primary therapy is not age dependent but the less favorable cause-specific survival in this cohort may reflect age-related postrecurrence treatment differences.

KW - Endometrial cancer Elderly

UR - http://www.scopus.com/inward/record.url?scp=84931568947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931568947&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2015.04.010

DO - 10.1016/j.ygyno.2015.04.010

M3 - Article

VL - 138

SP - 133

EP - 140

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 1

ER -